The Street’s Key Stock Analysts Research Reports

$ACAD, $ADBE, $BSX, $GS, $ICE, $NDAQ, $VRTX

Daily HeffX-LTN reviews dozens of  the Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.

Below is a list of The Street’s Key analysts outlook for Key issues for Tuesday, as follows:

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) was started as Buy with a 60 target price at Guggenheim.

Adobe Inc. (NASDAQ:ADBE) was reiterated as Buy and its target price was raised to 368 at Argus.

Boston Scientific Corp. (NYSE:BSX) was reiterated as Overweight and its target price was raised to 52 at Wells Fargo.

Goldman Sachs Group Inc. (NYSE:GS) was raised to Buy from Neutral with a 255 target price at Citigroup.

Intercontinental Exchange Inc. (NYSE:ICE) was started as Outperform at Credit Suisse.

Nasdaq Inc. (NASDAQ:NDAQ) was started as Outperform at Credit Suisse.

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) was reiterated as Buy and the target price was raised to 248 at Argus.

Stay tuned…

The following two tabs change content below.
HEFFX has become one of Asia’s leading financial services companies with interests in Publishing, Private Equity, Capital Markets, Mining, Retail, Transport and Agriculture that span every continent of the world. Our clearing partners have unprecedented experience in Equities, Options, Forex and Commodities brokering, banking, physical metals dealing, floor brokering and trading.